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Abstract
Teratoma formation in mice is today the most stringent test for pluripotency that is available for human plu-
ripotent cells, as chimera formation and tetraploid complementation cannot be performed with human cells.
The teratoma assay could also be applied for assessing the safety of human pluripotent cell-derived cell
populations intended for therapeutic applications. In our study we examined the spontaneous differentia-
tion behaviour of human embryonic stem cells (hESCs) in a perfused 3D multi-compartment bioreactor sys-
tem and compared it with differentiation of hESCs and human induced pluripotent cells (hiPSCs) cultured
in vitro as embryoid bodies and in vivo in an experimental mouse model of teratoma formation. Results from
biochemical, histological/immunohistological and ultrastuctural analyses revealed that hESCs cultured in
bioreactors formed tissue-like structures containing derivatives of all three germ layers. Comparison with
embryoid bodies and the teratomas revealed a high degree of similarity of the tissues formed in the biore-
actor to these in the teratomas at the histological as well as transcriptional level, as detected by comparative
whole-genome RNA expression proﬁling. The 3D culture system represents a novel in vitro model that per-
mits stable long-term cultivation, spontaneous multi-lineage differentiation and tissue formation of plurip-
otent cells that is comparable to in vivo differentiation. Such a model is of interest, e.g. for the development
of novel cell differentiation strategies. In addition, the 3D in vitro model could be used for teratoma studies
and pluripotency assays in a fully deﬁned, controlled environment, alternatively to in vivo mouse models.
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1. Introduction
Human embryonic stem cells (hESCs) are pluripotent cells
capable of unlimited self-renewal and differentiation into
cells representative of all three embryonic germ layers.
They hold large potential as a cell source for applications
in basic science, pharmacology, toxicology and cell-based
therapy development in regenerative medicine.
When transplanted into immune-compromised animals,
undifferentiated hESCs form teratomas, consisting of differ-
ent tissue types derived from all three germ layers
(Przyborski, 2005; Blum and Benvenisty, 2008). In human
stem cell research, teratoma formation in mice is used as
an important in vivo pluripotency assay, in conjunction with
analysis of pluripotency marker expression and in vitro dif-
ferentiation assays. It is themost stringentmethod available
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for testing the developmental potential of isolated and cul-
tured hESCs or other human pluripotent cells, such as
human induced pluripotent stem cells (hiPSCs), since germ
line transmission as applied for testing the pluripotency of
mouse ES cells is prohibited in hESCs research, for ethical
reasons (Heins et al., 2004; Valbuena et al., 2006; Adewumi
et al., 2007). In addition to this, teratomas represent an
alternative development model because developmental
processes cannot be investigated in intact mammalian
embryos. Teratomas exhibit arrangements of different tis-
sue types that in many ways recapitulate organogenesis
within the embryo (Przyborski, 2005). Studying teratomas
could result in a better understanding of the stepwise devel-
opmental processes and their molecular bases and might
provide useful information for the development of tissue-
engineering technologies (Aleckovic and Simon, 2008).
The teratoma assay could also be applied for assessing
the safety of human pluripotent stem cell-derived cell popu-
lations intended for therapeutic applications, because small
quantities of undifferentiated cells contaminating any trans-
plant material could be efﬁciently detected by their capacity
for multi-lineage differentiation. Currently, however, there
is no in vitromodel for teratoma formation available, there-
fore to reduce animal testing the development of newmeth-
ods is of great interest.
Flat plastic dishes of various formats are the most com-
monly used in vitro culture systems. These represent static
two-dimensional (2D) open-batch systems with discontinu-
ous medium exchange. Batch systems are characterized by
periodical changes of the culture environment, such as
metabolite accumulation and nutrient decrease in the cul-
ture medium between medium changes. Despite efforts to
stimulate cell aggregate formation by coating the 2D sur-
face with biomatrices, these systems are limited in support-
ing the generation of 3D tissue structures by stem cells.
In suspension, hESCs form multicellular aggregates, in
which the cells start to differentiate spontaneously. The for-
mation of these so-called embryoid bodies (EBs) is a well-
established hESC/hiPSC culture method (Itskovitz-Eldor
et al., 2000) considering three-dimensional (3D) techni-
ques, but under static conditions. EBs consist of differenti-
ated and undifferentiated cells that can be cavitated and
cystic. They are thought to resemble early post-implantation
embryos and frequently progress through a series of
differentiation stages (Desbaillets et al., 2000; Vallier and
Pedersen, 2005). EB culture can be performed until the
EBs start showing central necrosis, due to the limited mass
exchange in the body. The use of 3D perfusion culture mod-
els provides a promising option for in vitro teratoma gener-
ation from pluripotent stem cells, since they approximate
the physiological situation of the cells within the organism
more closely. We previously developed a four-compartment
capillary membrane technology for dynamic perfusion cul-
ture of primary cells and stem cells, with integral gas
exchange and decentralized medium supply avoiding non-
physiological gradients (Gerlach et al., 2003). Two interwo-
ven independently perfused capillary beds provide a more
homogeneous 3D environment and a third interwoven oxy-
genation capillary compartment facilitates obtaining cell
densities similar to those in natural tissues. Initial studies
on the culture ofmouse embryonic stem cells in the bioreac-
tors enabled controllable expansion or differentiation of the
cells, and showed the possibility of scaling up the technol-
ogy (Gerlach et al., 2010a, 2010b). The aim of this study
was to demonstrate the suitability of the bioreactor system
for establishing a 3D in vitro model for tissue formation by
hESCs. The growth and differentiation behaviour of hESCs
was examined in long-term culture experiments by the
analysis of metabolic parameters in the culture medium,
RNA expression proﬁling using microarrays, expression of
differentiationmarkers, histology and transmission electron
microscopy. The results were compared with those of
hiPSCs and hESCs cultured as embryoid bodies and
an in vivo teratoma model in immunodeﬁcient NOD/SCID
mice. In addition, the inﬂuences of co-cultivation with
feeder cells and of the culture medium used were
examined.
2. Materials and methods
2.1. hESCs expansion
The human embryonic stem cell line SA002 (Heins et al.,
2004) was provided by Cellartis (Gothenburg, Sweden).
Larger-scale cell expansion for bioreactor inoculation
was performed using the single-cell enzymatic dissocia-
tion (SCED) culture system, as described by Ellerstrom
et al. (2007). Brieﬂy, hESCs were cultured in VitroHES
medium (Vitrolife AB, Kungsbacka, Sweden; http://
www.vitrolife.com) supplemented with 10 ng/ml human
recombinant basic ﬁbroblast growth factor (bFGF; Pepro-
Tec) in culture dishes containing a high-density human
foreskin ﬁbroblasts (HFFs) layer. VitroHES was composed
as previously described (Amit et al., 2000; Heins et al.,
2004). Upon 80–90% conﬂuence, the hESCs were enzy-
matically dissociated, using TrypLE Select (Invitrogen),
and seeded onto fresh HFFs at split ratios between 1:4
and 1:10.
2.2. The investigated bioreactor
The multicompartment bioreactors used for this study
are composed of three independent, yet interwoven,
hollow-ﬁbre capillary membrane systems (Figure 1) that
are integrated into a two-component polyurethane housing
(PUR; Morton, Germany). Two hydrophilic capillary sys-
tems for medium perfusion are made of microporous poly-
ethersulphone capillary membranes with a molecular
weight (MW) cut-off of approximately 500 000 (mPES;
Membrana, Germany). The third system is made of
hydrophobic multilaminate hollow-ﬁbre membrane capil-
laries (MHF; Mitsubishi, Tokyo, Japan) to enable gas
exchange. The cells located within the extracapillary space
(cell compartment) are thus exposed to a decentralized
medium supply with high mass exchange rates and direct
membrane oxygenation via diffusion (for illustrations and
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technical descriptions, see Gerlach et al., 2010a, 2010b).
The bioreactor is integrated into a processor-controlled per-
fusion device with pressure and ﬂow regulation for modular
pumps, with exchangeable multichannel ﬂowheads and
gears for medium recirculation and substitution. A heating
unit provides a constant temperature within the perfusion
circuit. The ﬂow rates of air and CO2 were controlled using
integrated rotameters. Perfusion tubings with bubble traps
were made from standard medical-grade dialysis PVC
(B. Braun, Melsungen, Germany). Sterilization was per-
formed with ethylene oxide or formaldehyde gas, followed
by a degassing period of at least 7 days.
2.3. Bioreactor cultures
Before initial cell inoculation bioreactors underwent a con-
ditioning phase of 24–72h with recirculation of medium,
after which cell inoculation cultures were perfused at a ﬂow
rate of 22–30ml/min. The bioreactors were kept at 37C.
The ﬂow of the air/CO2 mixture in the gas compartment
was maintained at 40ml/min. The pH, partial pressures of
oxygen (pO2) and carbon dioxide (pCO2) and the acid/base
status were periodically measured (ABL 5, Radio Meter
Copenhagen, Copenhagen, Denmark) and the air:CO2 mix-
ing ratio was adjusted to maintain a stable pH of 7.2–7.3.
hESCs were cultured with or without co-inoculation of
inactivatedHFFs using VitroHESmedium (Vitrolife) supple-
mented with 10ng/ml bFGF and 50mg/ml gentamycin
(Biochrom) or Dulbecco’s modiﬁed Eagle’s medium
(DMEM)/F12 supplemented with 20% fetal calf serum
(FCS), 1% non-essential amino acids (NEAAs), 50mg/ml
gentamycin (all Biochrom) and 1%GlutaMax-I (Invitrogen)
as the culture medium. Table 1 lists the experiments per-
formed and the experimental conditions. After cell inocula-
tion, freshmediumwas continuously added to the perfusion
circuit, initially at a ﬂow rate of 2ml/h. The fresh medium
feed in all bioreactor experiments was adjusted considering
the parameters measured in the culture medium to main-
tain stable glucose levels, prevent accumulation of toxic
metabolic cell products and maintain a stable medium
osmolality.
2.4. Metabolic parameters in the perfusion
medium
The metabolic activity and differentiation of the cells
inside the bioreactors were characterized on a daily basis
by measuring soluble factors in the medium outﬂow and
in the recirculating medium. The following parameters
were measured, using automated clinical chemistry
analysers (Roche Diagnostics, Germany): a-fetoprotein,
alkaline phosphatase, alanine transaminase, aspartate
transaminase, b-human chorionic gonadotropin, c-peptide,
carcinoembryonic antigen, cytokeratin fragment 19,
erythropoetin, oestradiol, follicle-stimulating hormone,
g-glutamyltransferase, glucose, lactate, lactate dehydroge-
nase, luteinizing hormone, neuronspeciﬁc enolase,
osmolality, osteocalcin, pseudocholinesterase, progester-
one, prolactin, S-100, thyroid-stimulating hormone, tissue
plasminogen activator and transferrin. Additionally gluta-
mine, glutamate, glucose, lactate, ammonium, pH, sodium
and potassium were measured using a BioProﬁle 100 Plus
device (Nova Biomedical, USA). Activin A and insulin
were measured by enzyme-linked immunosorbent assays
(ELISAs), following the manufacturer’s recommendations
(activin A using products DY338, DY999, DY994, DY995,
from R&D Systems, Wiesbaden-Nordenstadt, Germany;
insulin using an ELISA from Invitrogen).
The production or consumption rate of each substance
was calculated per bioreactor per day by multiplying the
Figure 1. Bioreactor design. (a) Housing with tube connectors, partially opened to view the capillary systems. All membrane com-
partments are interwoven, forming a tight network. The smallest unit formed by interweaving is framed by two medium capillaries
(medium perfusion compartments; red and blue) and two gas capillaries (oxygenation compartment; yellow). This allows scale-up
without changing the smallest units. The corresponding capillaries of each compartment are bundled to common in- and outﬂow
heads to be connected to tube systems. Each capillary membrane compartment can be perfused independently. (b, c) The cells are
located within the extracapillary space [cell compartment, exemplary pictures show histological sections from ﬁbroblasts (b) and dif-
ferentiated hESCs (c) in the bioreactor]. The cell aggregate size in the cell compartment is limited by the space between the capillaries
with average intercapillary distances of 500mm. Cells are inoculated into the cell compartment via open-ending tubes, which allows
distribution of the injected cells within the cell compartment (not shown)
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actual waste volume of the day by the difference between
the substance concentration in the feed medium and that
in the waste medium.
2.5. Sample acquisition from the bioreactor
At the end of the scheduled culture period, the bioreac-
tors were shut down and the tubing was disconnected.
The lower bioreactor lid was opened and samples of the
cell mass, including the capillary layers, were cut out
using sterile scalpels and forceps for further analysis. For
histological analysis, samples were directly ﬁxed and
embedded as described below.
2.6. In vivo teratoma formation
All animal experiments were performed under the guide-
lines of the German Animal Protection Law, with the
approval of the responsible local authorities (Landesamt
für Gesundheit und Soziales Berlin; G 0221/03). Into
each recipient NOD/SCID mouse, an aliquot of 1–3106
cells from the cell suspension used for bioreactor inocula-
tion was injected subcutaneously within a Matrigel (BD
Biosciences) suspension. Body weights and tumour sizes
were measured once a week. For in vivo experiments the
same time schedule as for bioreactor experiments was
applied. The tumours were excised and used for RNA
expression proﬁling and histological analysis.
2.7. Embryoid body formation
Embryoid bodies (EBs) were generated by seeding hESCs
and hiPSCs harvested as clusters onto low-attachment
dishes in VitroHES medium without bFGF supplementa-
tion. At the time-points days 6 and 20, the EBs were
harvested and ﬁxed in 4% buffered formaldehyde solu-
tion, embedded in parafﬁn and cut into 2mm sections.
Haematoxtylin and eosin (H&E) staining was performed
according to standard laboratory procedures.
2.8. Expression proﬁling
To isolate RNA from cells/tissue cultured in the bioreac-
tor, excised capillaries were washed with PBS without
CaMg and incubated for 3min in 0.05–0.02% trypsin–
EDTA solution (Biochrom). Total RNA was isolated using
the RNeasy Kit (Qiagen, Hilden, Germany), following
the manufacturer’s protocol. The teratomas were dis-
rupted using a TissueLyser II, followed by homogenization
with a QIAshredder (both Quiagen). Single cells were
lysed by direct addition of lysis buffer to the cell pellet.
Biotin-labelled cRNA was generated using the Illumina
TotalPrep RNA Ampliﬁcation Kit (Ambion, USA) with
300 ng quality-checked total RNA as input. cRNA samples
were hybridized on Illumina human-8v2 BeadChips,
which harbour ca. 24,000 RefSeq transcripts (Kuhn
et al., 2004). In addition to the data generated in this
study, RNA expression proﬁle data from Illumina
human-8v3 BeadChips generated from EBs of two hiPSC
cell lines (iPS2 and iPS4; Prigione et al., 2010) and two
hESCs lines (H1 and H9; WiCell Institute, Madison, WI,
USA) that were formed using comparable culture condi-
tions (Prigione and Adjaye, 2010) were included in the
data analysis. Data analysis was performed using Bead-
Studio v 3 software (Illumina), MultiExperiment Viewer
(MeV) (Saeed et al., 2003) and Bioconductor (Gentleman
et al., 2004). Functional enrichment analysis was per-
formed using DAVID (http://david.abcc.ncifcrf.gov).
2.9. Histology
Samples were ﬁxed in 4% buffered formaldehyde solu-
tion, embedded in parafﬁn and cut into 5 mm sections.
H&E staining was performed according to standard labo-
ratory procedures.
The following primary antibodies were used for immu-
noﬂuorescence staining: monoclonal mouse anti-human
smooth muscle actin IgG2a (ASMA), monoclonal mouse
anti-human desmin IgG1 (Dako, Denmark), monoclonal
mouse anti-neuron-speciﬁc ßIII-Tubulin IgG2a (R&D
Systems), monoclonal mouse anti nestin IgG1 (Becton-
Dickinson), polyclonal goat anti HNF-3ß IgG, monoclo-
nal mouse anti OCT-4 IgG2b and polyclonal rabbit anti
vimentin IgG (Santa Cruz Biotechnology). As secondary
antibodies, the following polyclonal antibodies were
used: goat anti-mouse IgG-Cy2, goat anti-rabbit
IgG-Cy3 (Dianova), goat anti-mouse IgG2a-TRICT, goat
anti-mouse IgG-FITC, goat anti-mouse IgG-FITC, goat
anti-mouse IgG-Cy3, goat anti-mouse IgG-FITC (Jackson
Immunoresearch Laboratories, West Grove, PA, USA) and
donkey anti-goat IgG-Cy3 (Santa Cruz Biotechnology).
For non-speciﬁc staining of the nuclei, sections were
incubated with 4′,6-diamidino-2-phenylindole. Sections
were analysed using an inverse microscope (Axiovert
200M, Carl Zeiss, Germany) equipped with a CCD camera
(Retiga 2000R, QImaging, Canada). The pictures were
Table 1. Overview of the performed bioreactor experiments





hESC-A hESC HFF (irradiated) 5.7107 4.2107 VitroHES+10ng/ml bFGF 50
hESC-B hESC HFF (irradiated) 4.5107 4.6107 VitroHES+10ng/ml bFGF 50
hESC-C hESC 15.9107 VitroHES+10ng/ml bFGF 50
hESC-D hESC 15.6107 DMEM/F12+20% FCS+Glutamax+NEAA 50
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acquired and processed using the digital imaging soft-
ware Image Pro Plus (Media Cybernetics, USA).
For transmission electron microscopy (TEM), samples
were ﬁxed with 5% glutaraldehyde. After immersion for
30min in 60mM phosphate buffer, pH 7.3, the cellular
aggregates were postﬁxed in 2%OsO4 for 2h, progressively
dehydrated in ethanol and then embedded in Araldite
(Serva, Germany). Ultra-thin sections were contrasted with
uranyl acetate and Reynold’s lead citrate (Chroma,
Germany) before electron microscopic examination.
3. Results
3.1. Differentiation of hESCs in the bioreactor
Four long-term bioreactor experiments were carried out over
a period of 50days each (experiments hESC-A, hESC-B,
hESC-C, hESC-D; Table 1) and compared to 11 in vivo
teratoma assays. To analyse the impact of feeder cells, irradi-
ated HFFs were inoculated into the bioreactors 2days before
inoculation of hESCs in experiments hESC-A and hESC-B,
whereas experiments hESC-C and hESC-D were performed
without pre-inoculation of feeder cells. The culture medium
used in bioreactors hESC-A to -C contained serum replace-
ment and 10ng/ml bFGF.
In bioreactor hESC-D the culture medium was changed
to a nutrient-rich culture medium containing FCS, which
was chosen based on the hypothesis that such a medium
better approximates to the in vivo environment of the cells
when they are transplanted in a mouse teratoma forma-
tion assay and therefore will enhance differentiation. In
all experiments, bioreactors were inoculated with hESC
suspensions derived from 2D hESC/HFF co-cultures. FACS
analysis of the inoculated cell suspensions showed that
4513% of cells were positive for both OCT4 and SSEA4
and therefore can be assumed to represent undifferenti-
ated hESCs. The cells that were negative for one or
both pluripotency markers represent HFFs or other cell
types developed from the hESCs by differentiation (see
Supporting information, Supplementary methods and
Figure S1).
During culture glucose, lactate and LDH concentrations
were measured daily in the bioreactor perfusate and in
the medium circuit outﬂow to evaluate the metabolic activ-
ity of the cells and to detect potential cell damage. Glucose,
lactate and LDH showed similar time courses in bioreactors
hESC-A, -B and -C, while hESC-D performed with FCS-
containing nutrient-rich medium showed different time
proﬁles of these parameters. In bioreactors hESC-A, -B and
-C, a slow but constant increase of glucose consumption
and lactate production was observed over the culture
period, indicating cell proliferation. LDH levels decreased
after an initial peak, which presumably was due to cell
damage after cell inoculation (Figure 2a–c). In bioreactor
hESC-D, glucose, lactate and LDH showed constant levels
after an initial peak in LDH release (Figure 2d).
To identify soluble markers for potential cell differentia-
tion processes, several factors were measured in the
medium outﬂow. Here, interesting patterns in the
concentration of a-fetoprotein (AFP), b-human chorionic
gonadotropin (ß-hCG) and activin A could be detected
(Figure 2e–h). During human embryonic development,
AFP is ﬁrst expressed in the extraembryonic primitive endo-
derm (yolk sac), then in the hind- and midgut endoderm
and eventually in the foregut hepatic diverticulum. Later
on, AFP expression is found in the mesonephric duct and
tubules and also transiently in the developing pancreas
(Mizejewski, 2004). An onset of AFP production suggests
differentiation of hESCs towards primitive endoderm.
ß-hCG represents a marker for the differentiation of hESCs
towards trophectoderm (Xu et al., 2002) and is also known
as a clinical marker for germ cell tumours (Stenman et al.,
2006). In normal fetal development, ß-hCG is produced
soon after conception by the embryo, and later by the syncy-
tiotrophoblast. The detection of ß-hCG indicates the forma-
tion of cells of the trophectodermal lineage. Activin A was
described to have a strong positive effect on the self-renewal
of undifferentiated hESCs in vitro (Beattie et al., 2005;
James et al., 2005; Vallier et al., 2005; Xiao et al., 2006).
In bioreactors hESC-A and hESC-B, activin A production
showed initially high concentrations, subsequently
decreased and reached a minimum between days 15 and
25. This is the expected time span the inactivated HFF
feeder cells survive in the bioreactors. Afterwards, activin
A again slowly increased until the end of the bioreactor runs
(Figure 2e, f). In bioreactor hESC-C, in which the same cul-
ture medium was used but without additional feeder cells,
only a low rapidly decreasing activin A production could
be detected from the beginning of the experiment until
day 10 (Figure 2g). Bioreactor hESC-D run with the FCS-
containing nutrient-rich medium and without feeder cells
showed a decreasing activin A production that could only
be detected until day 32 (Figure 2h). This suggests that in
the presence of a high activin A concentration a differentia-
tion in the bioreactor is reduced. Results from parallel 2D
experiments with HFFs only showed that activin A produc-
tion is stimulated by bFGF in combination with medium
containing serum replacement (see Supporting informa-
tion, Supplementary methods and Figure S2). This suggests
that activin A in bioreactors hESC-A, -B and -C is produced
by the HFF feeder cells that were co-inoculated or were
contained in a low percentage in the inoculated hESC cell
suspensions derived from the hESC/HFF co-cultures.
In all experiments, the onset of AFP and/or ß-hCG pro-
duction characterized ongoing cell differentiation in the
bioreactor, which started as soon as the activin A concen-
tration in the medium reached a minimum. In bioreactors
hESC-A and -B, AFP production started to rise at about
days 15–20 and continued to increase during the entire
observed period of 50 days. ß-hCG started to increase in
these bioreactors at about day 20, peaked at around day
40 and decreased thereafter (Figure 2e, f). In contrast,
ß-hCG production started to increase from day 10 in bio-
reactor hESC-C performed without feeder cells but stayed
on a much lower level compared to bioreactors hESC-A
and -B. Most notably, the level of AFP exhibited an
exponential increase from day 10 onwards, with a peak
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of 350 ng/h on day 25 followed by a slight decrease until
day 37 and a stable level until the end of the experiment
(Figure 2g). In bioreactor hESC-D run with FCS-containing,
nutrient-rich medium, no ß-hCG production could be
detected throughout the experiment duration of 50days
and only low levels of AFP were observed, starting at day
41 (Figure 2h). Comparison of the production levels of
AFP and ß-HCG in bioreactors hESC-A to hESC-C could
indicate that the addition of HFF feeder cells enhances
differentiation towards trophectoderm, while in their ab-
sence differentiation towards primitive endoderm may be
favoured.
Considering the histology described below, these
results show that hESCs grow and differentiate in the
3D perfusion system used and that the culture behaviour
can be monitored by the analysis of soluble marker mole-
cules in the culture perfusate.
3.2. Histology
The morphology of the structures formed in vitro in the
bioreactors was analysed and compared with those of
EBs and of in vivo teratomas formed in NOD/SCID mice
by subcutaneous hESCs injection. The in vivo teratomas
were grown in parallel to the bioreactor cultures and for
the same time period. EBs derived from hESCs were cul-
tured for 6 or 20 days and EBs derived from hiPSC for 6,
20 or 50 days.
The histology of the bioreactors showed that the hESCs
differentiated and formed tissue-like structures compara-
ble to those formed in the teratomas, although the degree
of differentiation differed between the individual bioreac-
tors (Figure 3a–d, i–l). In EBs derived from hESCs and
hiPSCs, a much lower level of differentiation was found
compared to the bioreactor cultures and teratomas
(Figure 3m–p). They consisted of a limited number of cell
types; some were cavitated and even after 50 days of cul-
ture only a few tissue like structures could be observed
(Figure 3m–p; see also Supporting information, Figure
S4). In general, only connective tissue-like structures indi-
cating mesodermal differentiation, areas displaying a
morphology of embryonic neural rosettes, indicating ecto-
dermal differentiation but no epithelial or glandular
structures, could be observed. Additionally, in many EBs
necrotic areas could be observed, mostly in the centres
of the aggregates (Figure 3m, p; see also Supporting infor-
mation, Figure S4h, i). Such necrotic areas could not be
detected in any of the bioreactors or teratomas.
Bioreactors hESC-A to hESC-C exhibited a comparable
histology regarding the number and types of different
Figure 2. Time course of metabolic parameters and differentiation markers measured in the medium outﬂow of hESC bioreactors.
Graphs (a–d) show glucose consumption (green), lactate production (red) and LHD release (blue) in the bioreactors hESCs-A, -B,
-C and -D, respectively. Activin A production (pink), AFP production (dark blue) and ß-hCG production (yellow) by the cells in bio-
reactors is shown in graphs (e–h)
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tissues that could be detected (Figure 3). In all three bio-
reactors, structures and typical marker expression showing
differentiation into tissue of all three germ layers could be
detected, similar to the in vivo teratomas. However, in
comparison with the in vivo teratomas, some differences
in the proportions of individual tissue types were ob-
served. In particular, the material gained from the bioreac-
tors contained more ectodermal structures compared to
the teratomas. These structures could be identiﬁed by their
morphology, mostly in the form of embryonic neural
rosettes (Figure 3c, d) and the expression of the neural
markers nestin (Gilyarov, 2008) and ßIII-tubulin (Katsetos
et al., 2003a, 2003b) (Figure 4a, b, d, e). Mesodermally-
derived tissues were similarly observed in bioreactors and
teratomas. In general, a frequent occurrence of connective
tissue comprised of ﬁbroblasts and collagen-rich extracellu-
lar matrix (Figure 3d, f, h, i) and also numerous clusters of
hyaline cartilage (Figure 3a, e) were detected in the exam-
ined samples. The presence of mesodermal tissues was fur-
ther conﬁrmed by the immunohistochemical detection of
a-smoothmuscle actin characteristic for smoothmuscle cells
(Figure 4c, f), type III intermediate ﬁlament desmin, which
is one of the earliest protein markers for muscle tissue in
embryogenesis (Bar et al., 2004) (Figure 4g, j), and vimentin
as a general marker for mesenchymal cells (Figure 4h, k).
Endodermally-derived tissues were found frequently in the
examined samples and showed a similar quantity and distri-
bution in bioreactors and teratomas. These structures were
identiﬁed by their typical morphology in the shape of epithe-
lial (Figure 3b, j) and glandular structures (Figure 3k) and
also by ultrastructural features such as bioreactor.
The histology of bioreactor hESC-D cultured without
feeder cells and with FCS-containing medium differed
from that of the other bioreactors. Next to connective tis-
sue-like structures, some clusters of cells with a low
cytoplasm:nucleus ratio characteristic of undifferentiated
hESCs could be detected (see Supporting information,
Figure S3). Many of these clusters co-expressed the pluri-
potency markers OCT4 and TRA-1-81, which suggested
that they represented undifferentiated hESCs (see
Supporting information, Figure S3). Structures showing
further maturation were not observed.
3.3. Gene expression proﬁling
To compare the gene expression proﬁles of hESCs cultured
in the bioreactors with the in vivo teratomas that were
grown in parallel, whole-genome microarray proﬁling was
performed. For comparison of the expression proﬁles of
the bioreactor cultures and the teratomas to these of EBs
formed by hESCs and hiPSCs, data generated in nother
study (Prigione and Adjaye, 2010), using comparable
culture conditions, were included in the data analysis. As
controls, active and inactivated HFF samples from the
hESC/HFF cell suspensions, which were inoculated
into the bioreactors (abbreviated to SCED), and undifferen-
tiated hESCs cut from colonies growing in co-culture with
MEF were used (for a detailed sample description, see
Supporting information, Table S1).
Transcriptional similarities between the different sam-
ples were analysed by hierarchical clustering. The bio-
reactors that showed a similar histology and similar time
courses of differentiation factors, as described above, also
exhibited a similar gene expression proﬁle. These results
speciﬁcally show that the transcriptomes of bioreactors
hESC-A, -B and -C are very similar and therefore clus-
ter together (Figure 5a). This group of bioreactors was
also closely related to the group of in vivo teratomas,
which indicates a similar expression proﬁle of these
groups. Thus, a similar cell differentiation in these
bioreactors and in the teratomas can be assumed. Inter-
estingly, the expression proﬁle of bioreactor hESC-C
showed even more similarities to the expression proﬁles of
the teratomas than to the expression proﬁles of hESC-A
and -B.
Bioreactor hESC-D, which was cultured without feeder
cells and using FCS-containing medium, exhibited a tran-
scriptome similar to that of undifferentiated hESCs (line
SA002) grown in HFF and MEF 2D co-cultures. Again,
the result of morphological analysis of this bioreactor that
showed little to no differentiation was conﬁrmed by the
results of the gene expression analysis. Since the initially
high activin A production decreased much more slowly
and was maintained on a higher level compared to the
other bioreactors, the results from gene expression analy-
sis and from histological studies suggest that differentia-
tion in this reactor was suppressed by a ‘feeder cell-like’
activity. This could be due to differentiation of some
hESCs into ﬁbroblasts or ﬁbroblast-like cells with the abil-
ity to secrete activin A, and that are able to support the
self-renewal of undifferentiated hESCs, as has been
described in 2D cultures in the literature (Xu et al.,
2004; Stojkovic et al., 2005; Yoo et al., 2005; Gonzalez
et al., 2008).
The last group in the hierarchical tree consisted of the un-
differentiated hESC and hiPSC lines H1, H9, iPS2 and iPS4
and the EBs derived from them. Furthermore, this group
was closely related to the group of bioreactor hESC-D
and to the undifferentiated cells of cell line SA002 that were
used in the bioreactor and teratoma experiments. This indi-
cates that the EBs are less differentiated than the teratomas
and bioreactors and therefore cluster together with the
undifferentiated pluripotent cells. Comparison of the signif-
icantly expressed genes (detection values p≤0.01) in the
bioreactors, teratomas and EBs shows that bioreactors and
teratomas show a common expression for at least ﬁve more
genes than each of them with the EBs (Figure 5b). Again
these results conﬁrm the observations made at the histolog-
ical level.
To further compare the expression proﬁles of the group
of bioreactors that clustered together (hESC-A, -B and -C)
with the group of in vivo teratomas, a differential expression
analysis was performed. The results from the analysis
showed that 12 genes were differentially expressed in the
teratomas compared to 146 genes in the bioreactors, respec-
tively (Figure 5c, d). The resulting gene lists are relatively
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short, which is a further indication that the two groups are
closely related.
The differentially expressed genes in the bioreactors
were further analysed by functional annotation analysis.
The result of the functional annotation clustering per-
formed is shown in Table S2 (see Supporting informa-
tion). Most notable are the ﬁrst and fourth functional
groups, that contain gene ontology (GO) terms describ-
ing developmental or morphogenetic processes, and the
functional groups two and nine, that contain terms
describing neural differentiation.
The analysis of the expression proﬁles conﬁrmed the
observations obtained at the metabolic and histological
levels. The transcriptomes of teratoma structures gener-
ated in the bioreactors and in vivo teratomas are similar
and differ signiﬁcantly from these of the embryoid
bodies. There is only a very low number of genes that
are differentially expressed in the bioreactors and terato-
mas; analysis of these genes by functional annotation
clustering also indicated that neural differentiation was
pronounced in the bioreactors.
4. Discussion
In this paper, we introduce a 3D perfusion bioreactor system
that allows in vivo-like tissue formation by hESCs and
potentially by pluripotent stem cell types from other
sources. Our results from spontaneously differentiating
hESCs revealed high similarities with in vivo teratomas gen-
erated in mice and a lower degree of similarity to EBs
formed in suspension cultures in vitro, at the histological,
ultrastructural and RNA expression levels.
In both bioreactors and teratomas, differentiated tissues
of all three germ layers could be observed histologically,
with some differences in the proportion of individual
cell/tissue types. In particular, the relative number of
neural structures was distinctly larger in the bioreactor
Figure 3. H&E staining and electron microscopic analysis of tissue samples taken from bioreactors hESC-A, hESC-B and hESC-C,
embryoid bodies and from in vivo teratomas. In samples from bioreactors hESC-A, -B and -C, a similar morphology was observed,
showing that the hESCs differentiated and formed tissue-like structures. The morphology of these structures indicated differentiation
into all three germ layers. Cartilage (a) and connective tissue (d) represented mesodermal, epithelial structures endodermal (b) and
neuronal-like tissue (c) ectodermal differentiation (bar=50mm). In sections of the teratomas, in general predominantly mesodermal
and endodermal structures but only few ectodermal structures could be detected: (i) connective tissue (mainly collagen-rich) and
many adipocytes, (j) collagen-rich connective tissue, epithelial structures, adipose tissue, (k) pigmentary epithelial cells, epithelial
structures forming some glandular structures, connective tissue interspersed with adipocytes, and (l) connective tissue and glandular
structures (bar=50mm). Electron microscopic pictures of samples from the bioreactors show connective tissue (h) containing extra-
cellular matrix with collagen (f), hyaline cartilage composed of mature chondrocytes surrounded by a collagen-rich extracellular ma-
trix (e), and epithelial cells with kinocilia (g). In the embryoid bodies cultured for 6days (m, n) and 20days (o, p), only a limited
number of differentiated structures could be observed. Furthermore, in a high percentage of the EBs, necrotic areas were visible
(m, p; bar=50mm)
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than in the in vivo teratomas. This observation was also
reﬂected by the results of differential gene expression
analysis, where an enrichment for genes with a known
role in neural differentiation could be observed in
the bioreactor. These differences could be explained by
inﬂuencing factors speciﬁc for the in vitro and in vivo en-
vironment, respectively. For example, it has been
reported that one of the default pathways of spontane-
ous differentiation of hESCs in standard 2D culture con-
ditions is neural differentiation (Reubinoff et al., 2001;
Hornstein and Benvenisty, 2004). This observation is in
accordance with the embryonic development in vivo, in
which neurulation is the ﬁrst step in organogenesis.
The culture media and additives used could also have
contributed to an enrichment of neural cell types in the
bioreactors as compared to the teratomas. Especially
bFGF, which is known to play an important role in neu-
ral development (Gremo and Presta, 2000; Dono, 2003)
could be involved in these processes. It has been shown
in vitro that bFGF has a strong mitogenic effect on
neural stem and precursor cells (Hsu et al., 2007) and
is also used as a differentiation factor in protocols for
the neural differentiation of hESCs (Schwartz et al.,
2008). Therefore spontaneous differentiation of the
hESCs could have been inﬂuenced by the mitogenic
and neurotophic activity of bFGF that resulted in an
enrichment of neural cell types in the bioreactors. On
the other hand the low percentage of ectoderm-derived
tissues observed in the teratomas is in contrast to the
results of other studies on teratoma formation of hESCs
in mice, where a predominance of ectodermal and meso-
dermal differentiation is described (Gertow et al., 2004;
Adewumi et al., 2007). One explanation could be the
inﬂuence of the speciﬁc mouse model and the graft site,
which has already shown to have an impact on the tera-
toma growth and differentiation pattern (Cooke et al.,
2006).
Histological analysis of the EBs generated from the
hESC cell line SA002, which was also used for bioreactor
cultures, and an hiPSC cell line revealed only a limited
Figure 4. Immunoﬂuorescence staining of tissue samples taken from the bioreactors hESC-A, -B and -C and in vivo teratomas: ecto-
dermal markers nestin (a, d) and ßIII-tubulin (b, e), mesodermal marker a-smooth muscle actin (c, f), mesodermal markers desmin
(g, j) and vimentin (h, k) and endodermal marker HNF-3ß (i, l). All samples are co-stained with DAPI (blue; bar=50mm)
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Figure 5. Hierarchical clustering and Differential gene expression. (a) Hierarchical clustering with average linkage clustering, show-
ing that bioreactors hESC-A, -B and -C form a cluster and exhibit a similar expression proﬁle to the teratomas. (b) Venn diagram com-
paring the expressed genes in bioreactors, teratomas and embryoid bodies. (c, d) The comparison of gene expression proﬁles of
hESCs grown in bioreactors with those of teratomas was performed by signiﬁcance analysis of microarrays (SAM) testing. The anal-
ysis resulted in 12 genes differentially expressed in the teratomas (c) compared to 146 genes in the bioreactors respectively (d). (b, c,
are represented as heat maps clustered by hierarchical clustering of the samples and genes)
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number of morphologically distinct cell types and a much
lower degree of differentiation and tissue-like organi-
zation. This limited degree of differentiation is also in ac-
cordance with previously published studies examining EB
formation (Itskovitz-Eldor et al., 2000; Khoo et al., 2005;
Pekkanen-Mattila et al., 2010). Gene expression analysis
conﬁrmed observations at the histological level, showing
clustering of EBs together with undifferentiated cells. The
differences observed between the undifferentiated cells
and EBs of the cell lines SA002, H1, H9, iPS2 and iPS4 could
represent an inter-cell line variability of expression of pluri-
potency genes (Adewumi et al., 2007) and differences in
their in vitro differentiation capacity, as has been described
for many pluripotent cell lines (Osafune et al., 2008).
Another observation that has also been described previ-
ously is necrotic areas in the centres of the EBs (Khoo
et al., 2005; Pekkanen-Mattila et al., 2010). Comparable
areas could not be detected in the bioreactors or teratomas
and are most likely due to limited oxygen and nutrient
transport within the EBs when they reach a certain size.
These results indicate that by provision of dynamic mass
exchange, the bioreactor much better reﬂects the in vivo
situation, where it is supplied by the circulatory system of
the host organism. This is supported by the results of our
previous studies on mouse embryonic stem cell differentia-
tion using the same bioreactor technology, where only a
very low percentage of necrotic areas compared to mouse
EBs could be observed (Gerlach et al., 2010a, 2010b).
The results of this study also indicate possible strategies
to use the bioreactor for expansion of undifferentiated
cells, regarding the utilization of feeder cells and medium
composition. In the bioreactors hESC-A and hESC-B,
which were inoculated with additional HFF feeder cells,
the onset of differentiation indicated by the production
of AFP and ß-HCG was detected much later than in biore-
actor hESC-C without feeder cells. This also shows that
the bFGF in the used culture medium alone could not
keep the cell in an undifferentiated state. This cytokine
is known to promote the self-renewal of hESCs, both in
co-cultures with MEF (Amit et al., 2000) and in feeder-
free cultures, when used in high concentrations (Xu
et al., 2005a, 2005b). Thus, it can be hypothesized that
after the feeder cell activity decreased, the used bFGF
concentration was too low to sustain pluripotency and
hESCs started to differentiate. To examine the inﬂuence
of the culture medium on hESCs differentiation, a me-
dium supplemented with a high concentration of FCS
and no bFGF was used in bioreactor hESC-D, in which also
no additional HFF feeder cells were inoculated. In this
bioreactor the initially high activin A production de-
creased very slowly compared to all other reactors and
reached a minimum after about twice the length of the
time period observed in the bioreactors with feeder cells.
Histological analysis revealed not only ﬁbroblasts but also
clusters of cells exhibiting a low cytoplasm:nucleus ratio,
which is a typical feature of undifferentiated hESCs. In
addition, many of these clusters co-expressed the pluripo-
tency markers OCT4 and TRA-1-81, which suggests that
these clusters represent undifferentiated hESCs. These
results, together with the expression proﬁle that showed
a high correlation to hESC/HFF co-cultures, leads to the
interpretation that differentiation in this reactor was sup-
pressed by a ‘feeder cell-like’ activity. A possible explana-
tion for the origin of this ‘feeder cell-like’ activity is that,
under the inﬂuence of the culture medium used, some of
the hESCs differentiated into cells exhibiting self-renewal
supportive activity. This is in accordance with studies by
other groups that showed that autologous hESC-derived
feeder cells are able to support the self-renewal of undif-
ferentiated hESCs (Xu et al., 2004; Stojkovic et al., 2005;
Yoo et al., 2005; Gonzalez et al., 2008).
Based on these results, an approach to keep the hESCs in
their undifferentiated state can be seen in the use of condi-
tioned medium in the bioreactor. This could be addressed,
for example, by an indirect co-culture achieved by intercon-
necting two bioreactors in a perfusion circuit. In this way,
the cells are separated by themedium capillarymembranes,
while bidirectional exchange of soluble substances between
the cells in the individual bioreactors is possible. Such a set-
up would also allow the use of active feeder cells that
maintain their activity, in contrast to irradiated inactive
feeder cells.
In conclusion, our results show that the bioreactor has
the capacity to support differentiation of hESCs into 3D tis-
sue structures that contain cells of all three germ layers. Cell
structures formed in the bioreactor show a much higher
degree of differentiation and organization than pluripotent
cells differentiated in the form of EBs. These structures
closely resemble teratomas developed in an in vivo environ-
ment at the histological, ultrastructural and RNA expression
levels. The technology described could therefore be of inter-
est for the development of alternatives to in vivo teratoma
formation models for pluripotency assessment. The possi-
bility of scaling down the bioreactor technology used
(Zeilinger et al., 2011) allows reducing the costs of the sys-
tem and facilitates the performance of larger numbers of
parallel experiments. Furthermore, the method allows
online control of the culture parameters and online moni-
toring of differentiation processes and could, therefore, be
of interest for the development of tissue-engineering meth-
ods and embryotoxicity-testing assays. Since the bioreactor
system supports the generation of differentiated cells, the
technology could also be further developed for the produc-
tion of speciﬁc cell types under 3D perfusion conditions in a
closed system, by application of speciﬁc differentiation pro-
tocols. The latter would beneﬁt from the scalability of the
technology from laboratory to clinical translation or
industrial application requirements.
Acknowledgements
This work was supported by the German Federal Ministry for
Education and Research (BMBF) within the programme ‘Cell-
based Regenerative Medicine’ (Grant No. 01GN0526, 01GN0528,
01GN0530) and by the European Commission (Grant No. STREP-
CT-2005-018940). We thank Alexander Ring, Wolfram Haider,
Petra Schrade and Linda El-Ahmad for excellent help, technical
assistance and fruitful discussions.
Teratoma formation of hESCs in 3D bioreactors
Copyright © 2012 John Wiley & Sons, Ltd. J Tissue Eng Regen Med (2012)
DOI: 10.1002/term
Author contributions
H.S. designed and performed the study, performed and super-
vised the experiments, data and statistical analysis, interpreted
data and wrote the manuscript; A.W.-G. and K.E. performed ani-
mal experiments; J.Je., J.E., M.R., R.S. and P.Bj. provided the cell
line, performed experiments, evaluated experimental data and
provided useful discussions; J.Jo., A.P. and J.A. performed micro-
array experiments; T.U. provided technical assistance during
experiments and collected data; P.B. provided technical assis-
tance during experiments, collected data and performed IHC
experiments; K.Z. designed the study and interpreted data;
and J.C.G. had the original idea for the project and developed
the bioreactor technology. All authors commented on the
manuscript.
Supporting information on the
internet
The following supporting information may be found in
the online version of this article:
Figure S1. Flow cytometric analysis of the cell suspensions
inoculated into the bioreactors
Figure S2. Effect of different culture media and bFGF on HFFs
Figure S3. H&E and immunoﬂuorescence staining of tissue
samples taken from bioreactors hESCs-D
Figure S4. H&E staining of embryoid bodies derived from
human iPSCs and cultured for different periods of time
Table S1. Samples used for expression proﬁling
Table S2. Result of functional annotation clustering using DAVID
References
Adewumi O, Aﬂatoonian B, Ahrlund-Richter
L, et al. 2007, Characterization of human
embryonic stem cell lines by the Interna-
tional Stem Cell Initiative. Nat Biotechnol
25(7): 803–816.
Aleckovic M, Simon C. 2008; Is teratoma for-
mation in stem cell research a character-
ization tool or a window to developmental
biology? Reprod Biomed Online 17(2):
270–280.
Amit M, Carpenter MK, Inokuma MS, et al.
2000; Clonally derived human embryonic
stem cell lines maintain pluripotency and
proliferative potential for prolonged peri-
ods of culture. Dev Biol 227(2): 271–278.
Bar H, Strelkov SV, Sjoberg G, et al. 2004;
The biology of desmin ﬁlaments: how do
mutations affect their structure, assembly,
and organisation? J Struct Biol 148(2):
137–152.
Beattie GM, Lopez AD, Bucay N, et al.
2005; Activin A maintains pluripotency
of human embryonic stem cells in the
absence of feeder layers. Stem Cells 23(4):
489–495.
Blum B, Benvenisty N. 2008; The tumorige-
nicity of human embryonic stem cells.
Adv Cancer Res 100: 133–158.
Cooke MJ, Stojkovic M, Przyborski SA.
2006; Growth of teratomas derived from
human pluripotent stem cells is inﬂu-
enced by the graft site. Stem Cells Dev
15(2): 254–259.
Desbaillets I, Ziegler U, Groscurth P, et al.
2000; Embryoid bodies: an in vitro model
of mouse embryogenesis. Exp Physiol 85(6):
645–651.
Dono R. 2003; Fibroblast growth factors as
regulators of central nervous system
development and function. Am J Physiol
Regul Integr Comp Physiol 284(4):
R867–R881.
EllerstromC, Strehl R, Noaksson K, et al. 2007;
Facilitated expansion of human embryonic
stem cells by single-cell enzymatic dissocia-
tion. Stem Cells 25(7): 1690–1696.
Gentleman RC, Carey VJ, Bates DM, et al.
2004; Bioconductor: open software
development for computational biology
and bioinformatics. Genome Biol 5(10):
R80.
Gerlach JC, Hout M, Edsbagge J, et al. 2010a;
Dynamic 3D culture promotes spontane-
ous embryonic stem cell differentiation
in vitro. Tissue Eng Part C Methods 16(1):
115–121.
Gerlach JC, Lubberstedt M, Edsbagge J, et al.
2010b; Interwoven four-compartment
capillary membrane technology for
three-dimensional perfusion with decen-
tralized mass exchange to scale up embry-
onic stem cell culture. Cells Tissues Organs
192(1): 39–49.
Gerlach JC, Mutig K, Sauer IM, et al. 2003;
Use of primary human liver cells originat-
ing from discarded grafts in a bioreactor
for liver support therapy and the prospects
of culturing adult liver stem cells in bior-
eactors: a morphologic study. Transplanta-
tion 76(5): 781–786.
Gertow K, Wolbank S, Rozell BR, et al.
2004; Organized development from
human embryonic stem cells after injec-
tion into immunodeﬁcient mice. Stem Cells
Dev 13: 421–435.
Gilyarov AV. 2008; Nestin in central nervous
system cells. Neurosci Behav Physiol 38(2):
165–169.
Gonzalez R, Loring JF, Snyder EY. 2008;
Preparation of autogenic human feeder
cells for growth of human embryonic stem
cells. Curr Protoc Stem Cell Biol 1: units 1C
5.1–5.15.
Gremo F, Presta M. 2000; Role of ﬁbroblast
growth factor-2 in human brain: a focus
on development. Int J Dev Neurosci 18(2–
3): 271–279.
Heins N, Englund MCO, Sjoblom C, et al.
2004; Derivation, characterization, and
differentiation of human embryonic stem
cells. Stem Cells 22(3): 367–376.
Hornstein E, Benvenisty N. 2004; The ‘brainy
side’ of human embryonic stem cells. J
Neurosci Res 76(2): 169–173.
Hsu YC, Lee DC, Chiu IM. 2007; Neural
stem cells, neural progenitors, and neu-
rotrophic factors. Cell Transplant 16(2):
133–150.
Itskovitz-Eldor J, Schuldiner M, Karsenti D,
et al. 2000; Differentiation of human
embryonic stem cells into embryoid bodies
compromising the three embryonic germ
layers. Mol Med 6(2): 88–95.
James D, Levine AJ, Besser D, et al. 2005;
TGFb/activin/nodal signaling is necessary
for the maintenance of pluripotency in hu-
man embryonic stem cells. Development
132(6): 1273–1282.
Katsetos CD, Herman MM, Mork SJ.
2003a; Class III b-tubulin in human
development and cancer. Cell Motil
Cytoskel 55(2): 77–96.
Katsetos CD, Legido A, Perentes E, et al.
2003b; Class III b-tubulin isotype: a key
cytoskeletal protein at the crossroads of
developmental neurobiology and tumor
neuropathology. J Child Neurol 18(12):
851–866; discussion, 867.
Khoo ML, McQuade LR, Smith MS, et al.
2005; Growth and differentiation of
embryoid bodies derived from human
embryonic stem cells: effect of glucose
and basic ﬁbroblast growth factor. Biol
Reprod 73(6): 1147–1156.
Kuhn K, Baker SC, Chudin E, et al. 2004; A
novel, high-performance random array
platform for quantitative gene expres-
sion proﬁling. Genome Res 14(11):
2347–2356.
Mizejewski GJ. 2004; Biological roles of
alpha-fetoprotein during pregnancy and
perinatal development. Exp Biol Med (May-
wood) 229(6): 439–463.
Osafune K, Caron L, Borowiak M, et al.
2008; Marked differences in differentia-
tion propensity among human embryonic
stem cell lines. Nat Biotechnol 26(3):
313–315.
Pekkanen-Mattila M, Pelto-Huikko M, Kujala
V, et al. 2010; Spatial and temporal expres-
sion pattern of germ layer markers during
human embryonic stem cell differentiation
in embryoid bodies. Histochem Cell Biol
133(5): 595–606.
Prigione A, Adjaye J. 2010; Modulation of
mitochondrial biogenesis and bioenergetic
metabolism upon in vitro and in vivo differ-
entiation of human ES and iPS cells. Int J
Dev Biol 54(11–12): 1729–1741.
Prigione A, Fauler B, Lurz R, et al. 2010; The
senescence-related mitochondrial/oxida-
tive stress pathway is repressed in human
induced pluripotent stem cells. Stem Cells
28(4): 721–733.
Przyborski SA. 2005; Differentiation of human
embryonic stem cells after transplantation
in immune-deﬁcient mice. Stem Cells 23
(9): 1242–1250.
Reubinoff BE, Itsykson P, Turetsky T, et al.
2001; Neural progenitors from human
embryonic stem cells. Nat Biotechnol
19(12): 1134–1140.
H. Stachelscheid et al.
Copyright © 2012 John Wiley & Sons, Ltd. J Tissue Eng Regen Med (2012)
DOI: 10.1002/term
Saeed AI, Sharov V, White J, et al. 2003; TM4:
a free, open-source system for microarray
data management and analysis. Biotechni-
ques 34(2): 374–378.
Schwartz PH, Brick DJ, Stover AE, et al.
2008; Differentiation of neural lineage
cells from human pluripotent stem cells,
Methods 45(2): 142–158.
Stenman UH, Tiitinen A, Alfthan H, et al.
2006; The classiﬁcation, functions and
clinical use of different isoforms of HCG.
Hum Reprod Update 12(6): 769–784.
Stojkovic P, LakoM, Stewart R, et al. 2005; An
autogeneic feeder cell system that efﬁ-
ciently supports growth of undifferentiated
human embryonic stem cells. Stem Cells
23(3): 306–314.
Valbuena D, Galán A, Sánchez E, et al.
2006; Derivation and characterization
of three new Spanish human embryonic
stem cell lines (VAL-3 -4 -5) on human
feeder and in serum-free conditions.
Reprod Biomed Online 13(6): 875–886.
Vallier L, Alexander M, Pedersen RA.
2005; Activin/Nodal and FGF pathways
cooperate to maintain pluripotency of
human embryonic stem cells. J Cell Sci
118(pt 19): 4495–4509.
Vallier L, Pedersen RA. 2005; Human
embryonic stem cells: an in vitro model
to study mechanisms controlling pluri-
potency in early mammalian develop-
ment. Stem Cell Rev 1(2): 119–130.
Xiao L, Yuan X, Sharkis SJ. 2006; Activin A
maintains self-renewal and regulates ﬁbro-
blast growth factor, Wnt, and bone morpho-
genic protein pathways in human embryonic
stem cells. Stem Cells 24(6): 1476–1486.
Xu C, Jiang J, Sottile V, et al. 2004;
Immortalized ﬁbroblast-like cells derived
from human embryonic stem cells sup-
port undifferentiated cell growth. Stem
Cells 22(6): 972–980.
Xu C, Rosler E, Jiang J, et al. 2005a; Basic
ﬁbroblast growth factor supports undiffer-
entiated human embryonic stem cell
growth without conditioned medium.
Stem Cells 23(3): 315–323.
Xu RH, Chen X, Li DS, et al. 2002; BMP4
initiates human embryonic stem cell dif-
ferentiation to trophoblast. Nat Biotech-
nol 20(12): 1261–1264.
Xu R-H, Peck RM, Li DS, et al. 2005b; Basic
FGF and suppression of BMP signaling sus-
tain undifferentiated proliferation of human
ES cells. Nat Methods 2(3): 185–190.
Yoo SJ, Yoon BS, Kim JM, et al. 2005; Efﬁ-
cient culture system for human embryonic
stem cells using autologous human embry-
onic stem cell-derived feeder cells. Exp Mol
Med 37(5): 399–407.
Zeilinger K, Schreiter T, Darnell M, et al.
2011; Scaling down of a clinical three-
dimensional perfusion multicompartment
hollow ﬁber liver bioreactor developed
for extracorporeal liver support to an ana-
lytical scale device useful for hepatic phar-
macological in vitro studies. Tissue Eng
Part C Methods 17(5): 549–556.
Teratoma formation of hESCs in 3D bioreactors
Copyright © 2012 John Wiley & Sons, Ltd. J Tissue Eng Regen Med (2012)
DOI: 10.1002/term
